Mayo Clinic Q&A: Boosters reduce vulnerability to COVID-19 variants

Mayo Clinic Q&A: Boosters reduce vulnerability to COVID-19 variants

This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

Omicron, a new COVID-19 variant of concern, has been detected in all regions of the world, including North America. While research and clinical observations on the new strain are underway, it is not yet known what impact, if any, omicron will have on the immune response, transmissibility, or specific COVID-19 treatments.

The emergence of omicron is a reminder to take important steps to protect yourself against COVID-19.

"The answer is masking and boosters," says Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group.

Dr. Poland is encouraged by vaccine booster rates in the U.S. "In a relatively short period of time, about 36% of adults who are eligible have indeed gotten a booster," says Dr. Poland. "There's plenty of vaccine available. So in the strongest possible terms, I would recommend getting that booster."

Adults who are six months past completing their initial Moderna or Pfizer COVID-19 vaccination series are eligible to receive a booster dose, as are adults who are two months past completing their initial dose of the Johnson & Johnson vaccine.

On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron variant and COVID-19 boosters, and he answers some listener questions.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Episoder(500)

Mayo Clinic Proceedings: Diabetes and Novel Therapies for Diabetes

Mayo Clinic Proceedings: Diabetes and Novel Therapies for Diabetes

Host: Darryl S. Chutka, M.D.  Guest: Vinaya Simha, M.B.B.S., M.D.  For years, we saw very little change in the management of type 2 diabetes. However, over the past decade, numerous new pharmacologic ...

9 Apr 33min

Mayo Clinic Proceedings: Healthy Aging

Mayo Clinic Proceedings: Healthy Aging

Host: Darryl S. Chutka, M.D.  Guest: Robert Pignolo, M.D., Ph.D.  Our population is aging as our life expectancy increases with time. In general, we’re living longer than those before us. Aging is an ...

7 Apr 28min

Mayo Clinic Proceedings: Sleep Disorders and How They Adversely Affect Health

Mayo Clinic Proceedings: Sleep Disorders and How They Adversely Affect Health

Host: Darryl S. Chutka, M.D.  Guest: Bhanu Kolla, M.D.  We commonly take sleep for granted. That is, until our sleep quantity or quality is compromised. This can result in both mental and physical hea...

2 Apr 31min

Retinal Disorders

Retinal Disorders

Host: Darryl S. Chutka, M.D.  Guest: Brittni A. Scruggs, M.D., Ph.D.  There are a variety of eye disorders which involve the retina, and they all have the potential to cause significant vision loss or...

31 Mar 32min

Update in the Management of Hyperlipidemia

Update in the Management of Hyperlipidemia

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  Cardiovascular disease is highly prevalent in our society. Fortunately, we have a variety of treatment options to lower the risk of developi...

24 Mar 28min

Pulmonary Vascular Complications of Liver Disease

Pulmonary Vascular Complications of Liver Disease

Host: Darryl S. Chutka, M.D.  Guest: Kathryn del Valle, M.D.  Chronic liver disease can result in a variety of complications which can involve multiple organs. One of these complications can occur in ...

17 Mar 24min

Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Host: Darryl S. Chutka, M.D.  Guest: Stephen Ansell, M.D., Ph.D.  Non-Hodgkin’s Lymphoma is a group of hematologic malignancies originating in the lymphatic system. There are over 60 subtypes of lymph...

12 Mar 20min

Hodgkin's Lymphoma

Hodgkin's Lymphoma

Host: Darryl S. Chutka, M.D.  Guest: Stephen Ansell, M.D., Ph.D.  Hodgkin’s Lymphoma is an uncommon but very curable malignancy involving the lymphatic system. It most commonly presents in young adult...

10 Mar 24min

Populært innen Fakta

mikkels-paskenotter
fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
treningspodden
rss-strid-de-norske-borgerkrigene
rss-bisarr-historie
jakt-og-fiskepodden
hverdagspsyken
sinnsyn
tomprat-med-gunnar-tjomlid
fryktlos
level-up-med-anniken-binz
gravid-uke-for-uke
rss-kunsten-a-leve
rss-kull
takk-og-lov-med-anine-kierulf
hagespiren-podcast
uroskolen